Page 4 of 7
Where was this study done?
Study sites were in two countries.
Number of participants who received at least one dose of
the study medicines
Canada 14
United States 83
0 20 40 60 80 100
Number of participants
What were the main results of the study?
Study doctors collected blood samples and measured participants’ viral loads.
The table below shows the results for participants who had viral load assessed as:
• Detectable: 50 c/mL or more at Month 12 or at their last test before they
stopped taking part in the study.
• Undetectable: Less than 50 c/mL at Month 12.
Number of participants (percent) by viral load
CAB and RPV DTG and RPV
90 participants 7 participants
50 c/mL or more 0 0
Less than 50 c/mL 88 (98%) 7 (100%)
More information about the study results is available in the scientific results summary
(a link to the summary is provided at the end of this document).